FDA.reportPublic FDA data

0.5 ML pegvaliase-pqpz 20 MG/ML Prefilled Syringe

RxCUI
2046365
RxNorm name
0.5 ML pegvaliase-pqpz 20 MG/ML Prefilled Syringe
Display name
0.5 ML pegvaliase-pqpz 20 MG/ML Prefilled Syringe
Full name
0.5 ML pegvaliase-pqpz 20 MG/ML Prefilled Syringe
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761079Palynziqpegvaliase-pqpz351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PalynziqPEGVALIASE-PQPZBioMarin Pharmaceutical Inc.6dba844a-db02-44f8-8593-ce497ed9406c2026-03-02Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2046365

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
6dba844a-db02-44f8-8593-ce497ed9406c0.5 ML pegvaliase-pqpz 20 MG/ML Prefilled SyringeSCD36These highlights do not include all the information needed to use PALYNZIQ safely and effectively. See full prescribing information for PALYNZIQ. PALYNZIQ (pegvaliase-pqpz) injection, for subcutaneous use Initial U.S. Approval: 201820260302
6dba844a-db02-44f8-8593-ce497ed9406cpegvaliase-pqpz 10 MG in 0.5 mL Prefilled SyringePSN36These highlights do not include all the information needed to use PALYNZIQ safely and effectively. See full prescribing information for PALYNZIQ. PALYNZIQ (pegvaliase-pqpz) injection, for subcutaneous use Initial U.S. Approval: 201820260302
6dba844a-db02-44f8-8593-ce497ed9406cpegvaliase-pqpz 10 MG per 0.5 ML Prefilled SyringeSY36These highlights do not include all the information needed to use PALYNZIQ safely and effectively. See full prescribing information for PALYNZIQ. PALYNZIQ (pegvaliase-pqpz) injection, for subcutaneous use Initial U.S. Approval: 201820260302